C-Path
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Arizona, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1730 E River Rd Ste 200, Tucson, Arizona...Phone Number
(520) 547-3440Website
www.c-path.orgRevenue
$14.7 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
1
1
1
1
1
About C-Path
Critical Path Institute (C-Path) is a nonprofit organization that enhances drug and medical product development by facilitating collaboration among pharmaceutical companies, government agencies, patients, and academic institutions. With over 20 years of experience, C-Path focuses on accelerating the development of therapies for unmet medical needs through innovative tools and programs. Their offerings include various clinical trial enrichment tools aimed at optimizing trial designs for conditions such as Alzheimer's, Duchenne Muscular Dystrophy, and Parkinson's disease. The organization serves a broad range of stakeholders in the life sciences sector, including researchers, regulatory bodies, and patient advocacy groups.Explore more
C-Path Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is C-Path your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if C-Path had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when C-Path launches new products
Congratulate Masked Content for being promoted to Masked Content at C-Path
Earning: See what the market has to say on C-Path recently announced quarterly report
Check out if C-Path is spiking on competitors!
Funding: Get notified immidiatlly once C-Path has new funding data
C-Path, which may be a good buyer, showed buying intent in Masked Content Topic
Check if C-Path has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at C-Path
Find 2 more new buyers
Compare Similar Companies to C-Path
Compare insights from companies similar to C-Path, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5M
51-200
Private
-
2003
CG
Chuck GessnerSafety, Steward Observatory Building Emergency Operations Plan Head
Company Profile Activity
Activity Insights
C-Path is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
C-Path is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about C-Path.
C-Path Tech Stack
A closer look at the technologies used by C-Path
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Events
Person-Based
Pharmaceuticals, Regulations
Person-Based
Person-Based
C-Path News & Media
C-Path Names Karen Bernstein Board Chair and Welcomes Yalonda Howze and Milad Alucozai as Board Directors
C-Path strengthens its board with senior industry, legal and scientific expertise as it broadens the collaborations that advance drug development TUCSON, Ariz., July 15, 2026 /PRNewswire/ -- Critical Path Institute® (C-Path) today announced new leadership on its Board of Directors. Karen...Karen Bernstein, one of biotech's most influential voices, elected C-Path board chair
Critical Path Institute today announced that its Board of Directors has elected Karen Bernstein, Ph.D., as chair, effective July 1, 2026. Bernstein, co-founder and chair of BioCentury Inc., has served on the C-Path board since her appointment in March 2023. She succeeds M. Wainwright Fishburn, Jr., J.D., who concludes his tenure as chair after five years of service.C-Path Reaffirms Commitment to Advancing Regulatory Science for Disease-Modifying Therapies in Type 1 Diabetes
Regulatory milestone underscores opportunity for shared regulatory-science and evidence frameworks to support the next generation of therapies. TUCSON, Ariz., June 15, 2026 /PRNewswire/ -- Critical Path Institute® (C-Path), through its Type 1 Diabetes Consortium, today reaffirmed its...Critical Path Institute to Convene Drug Development Leaders at 2026 Global Impact Conference
Annual conference returns to Washington, D.C., Sept. 15-16; addresses challenges in establishing a new paradigm for how evidence of efficacy and safety is generated. TUCSON, Ariz., June 9, 2026 /PRNewswire/ -- Critical Path Institute® (C-Path) will host its 2026 Global Impact Conference...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding C-Path
Sign Up For FreeTo access detailed company insights
Critical Path Institute (C-Path) is a nonprofit organization that enhances drug and medical product development by facilitating collaboration among pharmaceutical companies, government agencies, patients, and academic institutions. With over 20 years of experience, C-Path focuses on accelerating the development of therapies for unmet medical needs... Read More
